GlassScriptPhysician profile
Paula D Hunter
NPI 1588695381
$3,763.73
in general payments reported to CMS, 2019-2025
17 companies · $661 in 2025
The $661 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $527 · 2023: $1,916 · 2024: $659 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.51 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $830.81 | 2022-2025 | Evenity, Repatha, Repatha |
| Novo Nordisk INC | $670.68 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $592.93 | 2022-2025 | Breztri, Farxiga, Nexium |
| Abbvie INC. | $478.78 | 2022-2023 | |
| Pfizer INC. | $289.37 | 2022-2025 | |
| Glaxosmithkline, LLC. | $179.92 | 2022-2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $157.21 | 2022-2023 | Mounjaro, Jardiance, Trulicity |
| Medtronic, INC. | $137.87 | 2023 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $134.41 | 2022-2025 | |
| Astellas Pharma US INC | $89.75 | 2023 | Myrbetriq, Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.55 | 2023 | Xifaxan |
| Exact Sciences Corporation | $34.07 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $27.70 | 2023 | Quviviq |
| Dexcom, INC. | $24.67 | 2023 | Dexcom G6 Transmitter |
| Corium, LLC | $21.31 | 2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.79 | 2022 | |
| Organon LLC | $13.91 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.